Ultan McDermott
Computational Theory and Mathematics · 2009–2016
A researcher in the Science corpus: 12 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Computational Theory and Mathematics — 12 citations into it
Whom Ultan McDermott trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- Richard D. Gonzalez (in Statistics and Probability)
- Chun Wei Yap (in Computational Theory and Mathematics)
Papers from Ultan McDermott's perspective
Ordered by how strongly the researchers Ultan McDermott trusts endorse each paper. Same corpus, a different order for every researcher.
- Addendum: Regularization and variable selection via the elastic net
- Random Forests
- Systematic variation in gene expression patterns in human cancer cell lines (Nature Genetics)
- Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer (New England Journal of Medicine)
- COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer
- The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity (Nature)
- A direct adaptive method for faster backpropagation learning: the RPROP algorithm
- Systematic identification of genomic markers of drug sensitivity in cancer cells (Nature)
- Anticancer drugs: To the rescue? (Nature reviews. Drug discovery)
- BRAF mutation predicts sensitivity to MEK inhibition (Nature)
Their papers
- Signatures of mutational processes in human cancer (2013) — 9,146 citations
- Systematic identification of genomic markers of drug sensitivity in cancer cells (2012) — 2,417 citations
- A chromatin-mediated reversible drug tolerant state in cancer cell subpopulations (2010) — 2,613 citations
- Machine Learning Prediction of Cancer Cell Sensitivity to Drugs Based on Genomic and Chemical Properties (2012) — 475 citations
- A Landscape of Pharmacogenomic Interactions in Cancer (2016) — 1,831 citations
- Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells (2012) — 3,577 citations
- Targeting MYCN in neuroblastoma by BET bromodomain inhibition. (2013) — 628 citations
- A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid Leukemia (2016) — 609 citations
- The Evolutionary History of Lethal Metastatic Prostate Cancer (2015) — 1,348 citations
- Prospective derivation of a Living Organoid Biobank of colorectal cancer patients (2015) — 2,171 citations
- COSMIC: exploring the world's knowledge of somatic mutations in human cancer (2014) — 2,319 citations
- Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK. (2009) — 1,860 citations